ResourceLife Sciences
IRDye<sup>®</sup> 800CW 2-DG Optical Probe is Described.
14 Jun 2011This application note from LI-COR outlines the use of IRDye® 800CW 2-DG, a fluorescent optical imaging agent that has been shown to be reactive with implanted tumors derived from a number of cell lines and should find use in research pertaining to tumor biology, its metastases, and diabetes. In this investigation, two examples in which IRDye 800CW 2-DG was used to detect subcutaneous A431 tumors are shown.